| - GRCh37:
- Chr3:181430537
- GRCh38:
- Chr3:181712749
| LOC108281177, SOX2, SOX2-OT | G130E | Anophthalmia/microphthalmia-esophageal atresia syndrome | Uncertain significance (Jun 29, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr3:181430226-181430227
- GRCh38:
- Chr3:181712438-181712439
| LOC108281177, SOX2, SOX2-OT | | Anophthalmia/microphthalmia-esophageal atresia syndrome | Uncertain significance (Nov 1, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr3:181430635
- GRCh38:
- Chr3:181712847
| LOC108281177, SOX2, SOX2-OT | M163V | Anophthalmia/microphthalmia-esophageal atresia syndrome | Likely benign (Jul 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:181431081
- GRCh38:
- Chr3:181713293
| SOX2, SOX2-OT | | Anophthalmia/microphthalmia-esophageal atresia syndrome | Likely benign (Jun 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:181431000
- GRCh38:
- Chr3:181713212
| SOX2, SOX2-OT | | Anophthalmia/microphthalmia-esophageal atresia syndrome | Likely benign (Sep 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:181430991
- GRCh38:
- Chr3:181713203
| SOX2, SOX2-OT | | Anophthalmia/microphthalmia-esophageal atresia syndrome | Likely benign (Aug 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:181430890
- GRCh38:
- Chr3:181713102
| SOX2-OT, SOX2 | A248S | Anophthalmia/microphthalmia-esophageal atresia syndrome | Uncertain significance (Sep 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:181430703
- GRCh38:
- Chr3:181712915
| SOX2, SOX2-OT | | Anophthalmia/microphthalmia-esophageal atresia syndrome | Likely benign (Apr 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:181430530
- GRCh38:
- Chr3:181712742
| LOC108281177, SOX2, SOX2-OT | G129fs | Anophthalmia/microphthalmia-esophageal atresia syndrome | Pathogenic (Sep 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:181430653
- GRCh38:
- Chr3:181712865
| LOC108281177, SOX2, SOX2-OT | G169S | Anophthalmia/microphthalmia-esophageal atresia syndrome | Uncertain significance (Feb 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:181430976
- GRCh38:
- Chr3:181713188
| SOX2, SOX2-OT | M276I | Anophthalmia/microphthalmia-esophageal atresia syndrome | Uncertain significance (Jul 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:181430848
- GRCh38:
- Chr3:181713060
| SOX2-OT, SOX2 | G234S | Anophthalmia/microphthalmia-esophageal atresia syndrome | Uncertain significance (Oct 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:181431060
- GRCh38:
- Chr3:181713272
| SOX2, SOX2-OT | | Anophthalmia/microphthalmia-esophageal atresia syndrome | Likely benign (Aug 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:181430628
- GRCh38:
- Chr3:181712840
| LOC108281177, SOX2, SOX2-OT | | Anophthalmia/microphthalmia-esophageal atresia syndrome | Pathogenic (Dec 18, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:181430571
- GRCh38:
- Chr3:181712783
| LOC108281177, SOX2, SOX2-OT | | Anophthalmia/microphthalmia-esophageal atresia syndrome | Likely benign (Jul 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:181430206-181430207
- GRCh38:
- Chr3:181712418-181712419
| LOC108281177, SOX2, SOX2-OT | G31fs | Anophthalmia/microphthalmia-esophageal atresia syndrome | Likely pathogenic (Jun 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:181430546
- GRCh38:
- Chr3:181712758
| LOC108281177, SOX2, SOX2-OT | A133G | Anophthalmia/microphthalmia-esophageal atresia syndrome | Uncertain significance (Jul 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:181430233
- GRCh38:
- Chr3:181712445
| LOC108281177, SOX2, SOX2-OT | A29T | Anophthalmia/microphthalmia-esophageal atresia syndrome | Uncertain significance (Oct 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:181430985
- GRCh38:
- Chr3:181713197
| SOX2, SOX2-OT | | Anophthalmia/microphthalmia-esophageal atresia syndrome | Likely benign (May 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:181430200-181430201
- GRCh38:
- Chr3:181712412-181712413
| LOC108281177, SOX2, SOX2-OT | S18K | not provided, Anophthalmia/microphthalmia-esophageal atresia syndrome | Conflicting interpretations of pathogenicity (Nov 15, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr3:181430315
- GRCh38:
- Chr3:181712527
| LOC108281177, SOX2, SOX2-OT | R56P | Anophthalmia/microphthalmia-esophageal atresia syndrome | Uncertain significance | criteria provided, single submitter |
| - GRCh37:
- Chr3:181430610
- GRCh38:
- Chr3:181712822
| LOC108281177, SOX2, SOX2-OT | N154K | Anophthalmia/microphthalmia-esophageal atresia syndrome | Uncertain significance (Aug 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:181430389
- GRCh38:
- Chr3:181712601
| LOC108281177, SOX2, SOX2-OT | L81fs | Anophthalmia/microphthalmia-esophageal atresia syndrome | Likely pathogenic (Jul 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:181430477
- GRCh38:
- Chr3:181712689
| LOC108281177, SOX2, SOX2-OT | Y110S | Anophthalmia/microphthalmia-esophageal atresia syndrome | Pathogenic | criteria provided, single submitter |
| - GRCh37:
- Chr3:181430911-181430912
- GRCh38:
- Chr3:181713123-181713124
| SOX2, SOX2-OT | S257fs | Anophthalmia/microphthalmia-esophageal atresia syndrome | Pathogenic (Aug 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:181431009
- GRCh38:
- Chr3:181713221
| SOX2, SOX2-OT | | Anophthalmia/microphthalmia-esophageal atresia syndrome | Benign (Aug 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:181431038
- GRCh38:
- Chr3:181713250
| SOX2, SOX2-OT | H297R | Anophthalmia/microphthalmia-esophageal atresia syndrome, Inborn genetic diseases | Conflicting interpretations of pathogenicity (Nov 29, 2021) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr3:181430708
- GRCh38:
- Chr3:181712920
| SOX2-OT, SOX2 | N187S | Anophthalmia/microphthalmia-esophageal atresia syndrome | Benign (Oct 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:181430688
- GRCh38:
- Chr3:181712900
| LOC108281177, SOX2, SOX2-OT | | Anophthalmia/microphthalmia-esophageal atresia syndrome | Likely benign (Apr 17, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:181430616
- GRCh38:
- Chr3:181712828
| LOC108281177, SOX2, SOX2-OT | | Anophthalmia/microphthalmia-esophageal atresia syndrome | Likely benign (Jul 6, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:181430685-181430686
- GRCh38:
- Chr3:181712897-181712898
| LOC108281177, SOX2, SOX2-OT | Y180fs | Anophthalmia/microphthalmia-esophageal atresia syndrome | Pathogenic (Jun 22, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:181430645
- GRCh38:
- Chr3:181712857
| LOC108281177, SOX2, SOX2-OT | W166* | Anophthalmia/microphthalmia-esophageal atresia syndrome | Pathogenic (Aug 28, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:181430261
- GRCh38:
- Chr3:181712473
| LOC108281177, SOX2, SOX2-OT | P38L | Anophthalmia/microphthalmia-esophageal atresia syndrome | Uncertain significance (Oct 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:181430737
- GRCh38:
- Chr3:181712949
| SOX2, SOX2-OT | M197V | Anophthalmia/microphthalmia-esophageal atresia syndrome | Uncertain significance (Nov 20, 2020) | no assertion criteria provided |
| - GRCh37:
- Chr3:181430478
- GRCh38:
- Chr3:181712690
| LOC108281177, SOX2, SOX2-OT | Y110* | Anophthalmia/microphthalmia-esophageal atresia syndrome | Likely pathogenic (Dec 9, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr3:181431017
- GRCh38:
- Chr3:181713229
| SOX2, SOX2-OT | S290T | Inborn genetic diseases, Anophthalmia/microphthalmia-esophageal atresia syndrome, not provided
| Conflicting interpretations of pathogenicity (Jul 17, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr3:181430709
- GRCh38:
- Chr3:181712921
| SOX2, SOX2-OT | | not provided, Anophthalmia/microphthalmia-esophageal atresia syndrome | Likely benign (Aug 15, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:181430988
- GRCh38:
- Chr3:181713200
| SOX2-OT, SOX2 | | Anophthalmia/microphthalmia-esophageal atresia syndrome, not provided | Likely benign (Aug 19, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:181430323
- GRCh38:
- Chr3:181712535
| SOX2-OT, LOC108281177, SOX2 | M59fs | Anophthalmia/microphthalmia-esophageal atresia syndrome | Pathogenic (Aug 24, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:181430646
- GRCh38:
- Chr3:181712858
| LOC108281177, SOX2, SOX2-OT | W166* | not provided, Anophthalmia/microphthalmia-esophageal atresia syndrome | Pathogenic (Jun 17, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:181430435
- GRCh38:
- Chr3:181712647
| LOC108281177, SOX2, SOX2-OT | R96P | Anophthalmia/microphthalmia-esophageal atresia syndrome | Likely pathogenic (Aug 27, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:181430170
- GRCh38:
- Chr3:181712382
| LOC108281177, SOX2, SOX2-OT | E8* | Anophthalmia/microphthalmia-esophageal atresia syndrome | Likely pathogenic (Nov 26, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr3:181431088-181431089
- GRCh38:
- Chr3:181713300-181713301
| SOX2, SOX2-OT | S315fs | Anophthalmia/microphthalmia-esophageal atresia syndrome | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr3:181430206-181430207
- GRCh38:
- Chr3:181712418-181712419
| LOC108281177, SOX2, SOX2-OT | G20fs | Anophthalmia/microphthalmia-esophageal atresia syndrome | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr3:181430202
- GRCh38:
- Chr3:181712414
| LOC108281177, SOX2, SOX2-OT | G20fs | Anophthalmia/microphthalmia-esophageal atresia syndrome | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr3:181430684-181430685
- GRCh38:
- Chr3:181712896-181712897
| LOC108281177, SOX2, SOX2-OT | Q182fs | Anophthalmia/microphthalmia-esophageal atresia syndrome | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr3:181430688
- GRCh38:
- Chr3:181712900
| LOC108281177, SOX2, SOX2-OT | P181fs | not provided | Pathogenic (Dec 21, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr3:181430164
- GRCh38:
- Chr3:181712376
| LOC108281177, SOX2, SOX2-OT | E6* | Anophthalmia/microphthalmia-esophageal atresia syndrome | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr3:181430546
- GRCh38:
- Chr3:181712758
| LOC108281177, SOX2, SOX2-OT | G135fs | not provided | Pathogenic (May 5, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr3:181430748
- GRCh38:
- Chr3:181712960
| SOX2, SOX2-OT | Y200* | Anophthalmia/microphthalmia-esophageal atresia syndrome | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr3:181431089
- GRCh38:
- Chr3:181713301
| SOX2, SOX2-OT | L314fs | Anophthalmia/microphthalmia-esophageal atresia syndrome | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr3:181430314
- GRCh38:
- Chr3:181712526
| LOC108281177, SOX2, SOX2-OT | R56G | Anophthalmia/microphthalmia-esophageal atresia syndrome | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr3:181430125-181430180
- GRCh38:
- Chr3:181712337-181712392
| LOC108281177, SOX2, SOX2-OT | M1fs | Anophthalmia/microphthalmia-esophageal atresia syndrome | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr3:181430631-181430632
- GRCh38:
- Chr3:181712843-181712844
| LOC108281177, SOX2, SOX2-OT | M163fs | Anophthalmia/microphthalmia-esophageal atresia syndrome | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr3:181430730-181430731
- GRCh38:
- Chr3:181712942-181712943
| SOX2, SOX2-OT | | Anophthalmia/microphthalmia-esophageal atresia syndrome | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr3:181430976
- GRCh38:
- Chr3:181713188
| SOX2-OT, SOX2 | M276fs | Anophthalmia/microphthalmia-esophageal atresia syndrome | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr3:181430205-181430206
- GRCh38:
- Chr3:181712417-181712418
| LOC108281177, SOX2, SOX2-OT | | Anophthalmia/microphthalmia-esophageal atresia syndrome | Uncertain significance | no assertion criteria provided |
| - GRCh37:
- Chr3:181430458
- GRCh38:
- Chr3:181712670
| LOC108281177, SOX2, SOX2-OT | E104* | Anophthalmia/microphthalmia-esophageal atresia syndrome | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr3:181430279
- GRCh38:
- Chr3:181712491
| LOC108281177, SOX2, SOX2-OT | P44R | Anophthalmia/microphthalmia-esophageal atresia syndrome | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr3:181431064-181431073
- GRCh38:
- Chr3:181713276-181713285
| SOX2, SOX2-OT | I308fs | Anophthalmia/microphthalmia-esophageal atresia syndrome | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr3:180834336-183551661
| ATP11B, SOX2, SOX2-OT, YEATS2, DCUN1D1, B3GNT5, KLHL24, KLHL6, MCF2L2, PARL, LAMP3, MAP6D1, MCCC1 | | Anophthalmia/microphthalmia-esophageal atresia syndrome | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr3:180913778-181432287
| SOX2, SOX2-OT | | Anophthalmia/microphthalmia-esophageal atresia syndrome | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr3:181431007
- GRCh38:
- Chr3:181713219
| SOX2, SOX2-OT | A287P | Anophthalmia/microphthalmia-esophageal atresia syndrome | Uncertain significance (Mar 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:182871341-182987855
| B3GNT5, LAMP3, MCF2L2 | | Anophthalmia/microphthalmia-esophageal atresia syndrome | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr3:182902731-182945128
| MCF2L2 | | Anophthalmia/microphthalmia-esophageal atresia syndrome | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr3:181171210-184706091
| ECE2, FAM131A, HTR3C, HTR3D, HTR3E, KLHL24, KLHL6, LAMP3, MCCC1, MCF2L2, MAGEF1, MAP6D1, MIR1224, PARL, POLR2H, PSMD2, SOX2, SOX2-OT, THPO, VPS8, VWA5B2, YEATS2, ABCC5, ABCF3, ALG3, AP2M1, ATP11B, B3GNT5, CLCN2, CAMK2N2, CHRD, DCUN1D1, EIF2B5, EIF4G1, EPHB3, DVL3 | | Anophthalmia/microphthalmia-esophageal atresia syndrome | Pathogenic | no assertion criteria provided |
| | | | Anophthalmia/microphthalmia-esophageal atresia syndrome | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr3:180102701-181991155
| SOX2-OT, TTC14, CCDC39, DNAJC19, FXR1, SOX2 | | Anophthalmia/microphthalmia-esophageal atresia syndrome | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr3:181430227-181430228
- GRCh38:
- Chr3:181712439-181712440
| LOC108281177, SOX2, SOX2-OT | N33fs | Anophthalmia/microphthalmia-esophageal atresia syndrome | Pathogenic (Feb 8, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr3:181430533-181430536
- GRCh38:
- Chr3:181712745-181712748
| SOX2-OT, LOC108281177, SOX2 | G130fs | Anophthalmia/microphthalmia-esophageal atresia syndrome | Pathogenic (Aug 30, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:181430291
- GRCh38:
- Chr3:181712503
| LOC108281177, SOX2, SOX2-OT | F48S | Anophthalmia/microphthalmia-esophageal atresia syndrome | Likely pathogenic (Aug 27, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:181430248
- GRCh38:
- Chr3:181712460
| LOC108281177, SOX2, SOX2-OT | Q34* | Anophthalmia/microphthalmia-esophageal atresia syndrome | Uncertain significance (Dec 3, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr3:181430150-181430151
- GRCh38:
- Chr3:181712362-181712363
| LOC108281177, SOX2, SOX2-OT | Y2fs | Anophthalmia/microphthalmia-esophageal atresia syndrome | Pathogenic (Aug 31, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:181430201
- GRCh38:
- Chr3:181712413
| LOC108281177, SOX2, SOX2-OT | S18* | Anophthalmia/microphthalmia-esophageal atresia syndrome | Pathogenic (Dec 19, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr3:181430577
- GRCh38:
- Chr3:181712789
| LOC108281177, SOX2, SOX2-OT | | Anophthalmia/microphthalmia-esophageal atresia syndrome | Likely benign (Oct 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:181431009
- GRCh38:
- Chr3:181713221
| SOX2, SOX2-OT | | Anophthalmia/microphthalmia-esophageal atresia syndrome | Likely benign (Oct 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:181430379
- GRCh38:
- Chr3:181712591
| LOC108281177, SOX2, SOX2-OT | | Anophthalmia/microphthalmia-esophageal atresia syndrome | Benign (Aug 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:181430533-181430534
- GRCh38:
- Chr3:181712745-181712746
| LOC108281177, SOX2, SOX2-OT | G129fs | Anophthalmia/microphthalmia-esophageal atresia syndrome | Pathogenic (Aug 31, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr3:181430224
- GRCh38:
- Chr3:181712436
| LOC108281177, SOX2, SOX2-OT | T26A | Anophthalmia/microphthalmia-esophageal atresia syndrome, not provided | Uncertain significance (Apr 8, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:181430205-181430206
- GRCh38:
- Chr3:181712417-181712418
| LOC108281177, SOX2, SOX2-OT | G31fs | Anophthalmia/microphthalmia-esophageal atresia syndrome | Pathogenic (Aug 28, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:181430572
- GRCh38:
- Chr3:181712784
| SOX2-OT, LOC108281177, SOX2 | G142R | Anophthalmia/microphthalmia-esophageal atresia syndrome | Uncertain significance (Aug 26, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:181430485
- GRCh38:
- Chr3:181712697
| LOC108281177, SOX2, SOX2-OT | R113W | Anophthalmia/microphthalmia-esophageal atresia syndrome | Uncertain significance (Aug 20, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:181430989-181431008
- GRCh38:
- Chr3:181713201-181713220
| SOX2, SOX2-OT | A281fs | Anophthalmia/microphthalmia-esophageal atresia syndrome | Pathogenic (Aug 2, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:181430314
- GRCh38:
- Chr3:181712526
| LOC108281177, SOX2, SOX2-OT | R56W | Anophthalmia/microphthalmia-esophageal atresia syndrome | Uncertain significance (Aug 31, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:181430545
- GRCh38:
- Chr3:181712757
| LOC108281177, SOX2, SOX2-OT | A133T | Anophthalmia/microphthalmia-esophageal atresia syndrome | Likely benign (Aug 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:181430688
- GRCh38:
- Chr3:181712900
| LOC108281177, SOX2, SOX2-OT | Y180* | Anophthalmia/microphthalmia-esophageal atresia syndrome | Pathogenic (Jul 13, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:181430210-181430226
- GRCh38:
- Chr3:181712422-181712438
| LOC108281177, SOX2, SOX2-OT | N24fs | Inborn genetic diseases | Pathogenic (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr3:181430391
- GRCh38:
- Chr3:181712603
| LOC108281177, SOX2, SOX2-OT | | Anophthalmia/microphthalmia-esophageal atresia syndrome, not specified | Likely benign (Feb 21, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:181430193
- GRCh38:
- Chr3:181712405
| LOC108281177, SOX2, SOX2-OT | | not provided, Anophthalmia/microphthalmia-esophageal atresia syndrome | Likely benign (Oct 17, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:181430390-181430391
- GRCh38:
- Chr3:181712602-181712603
| LOC108281177, SOX2, SOX2-OT | L82fs | Anophthalmia/microphthalmia-esophageal atresia syndrome | Pathogenic (Feb 17, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:181430302-181430303
- GRCh38:
- Chr3:181712514-181712515
| LOC108281177, SOX2, SOX2-OT | R53fs | Anophthalmia/microphthalmia-esophageal atresia syndrome | Pathogenic (Sep 2, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:181430129-181592675
- GRCh38:
- Chr3:181712341-181874887
| LOC108281178, LOC123256955, LOC108281177, SOX2, SOX2-OT | | Anophthalmia/microphthalmia-esophageal atresia syndrome | Pathogenic (Sep 15, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr14:60976501
- GRCh38:
- Chr14:60509783
| C14orf39, SIX6 | E129K | not provided, Anophthalmia-microphthalmia syndrome, Colobomatous optic disc-macular atrophy-chorioretinopathy syndrome, Anophthalmia/microphthalmia-esophageal atresia syndrome | Conflicting interpretations of pathogenicity (Oct 28, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr3:181430628
- GRCh38:
- Chr3:181712840
| LOC108281177, SOX2, SOX2-OT | Y160* | not provided, Anophthalmia/microphthalmia-esophageal atresia syndrome | Pathogenic (Dec 5, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:181430201-181430202
- GRCh38:
- Chr3:181712413-181712414
| LOC108281177, SOX2, SOX2-OT | G21fs | not provided, Anophthalmia/microphthalmia-esophageal atresia syndrome | Pathogenic (Sep 3, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:181430601
- GRCh38:
- Chr3:181712813
| LOC108281177, SOX2, SOX2-OT | | not provided, not specified, Anophthalmia/microphthalmia-esophageal atresia syndrome
| Benign (Oct 28, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:181430212
- GRCh38:
- Chr3:181712424
| LOC108281177, SOX2, SOX2-OT | | not provided, Anophthalmia/microphthalmia-esophageal atresia syndrome | Conflicting interpretations of pathogenicity (Aug 19, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr3:181430982
- GRCh38:
- Chr3:181713194
| SOX2, SOX2-OT | | not specified, not provided, Anophthalmia/microphthalmia-esophageal atresia syndrome
| Benign/Likely benign (Oct 25, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:181430207-181430226
- GRCh38:
- Chr3:181712419-181712438
| LOC108281177, SOX2, SOX2-OT | N24fs | not provided, Anophthalmia/microphthalmia-esophageal atresia syndrome, Septo-optic dysplasia sequence
| Pathogenic (Jun 17, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:181430982
- GRCh38:
- Chr3:181713194
| SOX2, SOX2-OT | G280fs | Anophthalmia/microphthalmia-esophageal atresia syndrome | Pathogenic (Jul 1, 2011) | no assertion criteria provided |